A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

Trattler: Patients with severe dry eye can in some cases be exceptionally challenging, and it can feel as if therapies are ...

Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Competition to deploy commercial brain-computer interfaces is heating up. Science Corporation—a competitor to Neuralink founded by the former president of Elon Musk’s brain-interface venture—has ...

AI-enabled equipment holds the largest market share in the ophthalmic equipment market because of its widespread availability ...

Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.

Loss of the glutamate transporters EAAT5b and EAAT7 disrupts wavelength-specific visual processing and UV-dependent prey detection in zebrafish, revealing their key roles in modulating light ...

A wireless electronic prosthesis implanted under the retina has been shown to restore central vision in people with an advanced form of dry age-related macular degeneration, leading to improvement in ...

ORLANDO — At 48 weeks, MCO-010, an optogenetic therapy, demonstrated gains in visual acuity in Stargardt disease, according to a study presented at the American Academy of Ophthalmology meeting.